Accelerating research to patient impact
We can support you to bring your translational kidney research closer to kidney patients:
- Benefit from our scientific expertise, drug discovery experience and practical insight
- Strengthen funding applications and identify opportunities to accelerate development
- Leverage our network of researchers, clinicians and wider kidney community
- Access patient and public involvement and engagement support to ensure your innovation reflects patient needs
- We are members of the ABPI patient organisation forum and adhere to the ABPI code of practice.
Ways we can support you
Talk to us about expertise, connections and funding opportunities.
Share your ideas
We want to hear about new ideas and innovations that could make a difference to patients.
Tell us about your idea through our 'open door'.
Industry Partnership Programme
We collaborate with organisations across the life sciences sector; pharma, biopharma, biotech and medtech to facilitate and drive new research projects.
A programme for businesses who want to collaborate to support the development of products, treatments, therapies and diagnostics for kidney disease.
Supporting early innovation
Through our translational funding and social investments, we support academic and NHS researchers and SMEs across therapeutics, devices and diagnostics.
We invest in early-stage startup propositions and companies to bridge the gap between innovative ideas and outcomes for kidney patients.
Translation Accelerator Kidney Award Scheme
Funding and support to accelerate the translation of scientific discoveries into new, effective solutions to help understand, prevent, protect and treat kidney disease.
Research news highlights
Read about the latest life-saving research we’re funding.
Got a question? Get in touch.
For more information or if you have any questions, get in touch with our translation, innovation and enterprise team. We're happy to talk.
Get our Research Roundup email
Hear about the latest opportunities for researchers - including funding opportunities, conferences, plus the latest research.